Crisaborole Improves Sleep Disruption in Children With Eczema

Crisaborole therapy for atopic dermatitis (AD) improves sleep outcomes in pediatric patients with mild-to-moderate AD and their families.

Related Keywords

,Dermatology Life Quality Index ,Dermatitis Family Impact ,Patient Oriented Eczema Measure ,Investigator Static Global Assessment ,